Skip to content

Ernest Barbosa, MD

NPI 1568409340ActiveIndividual· Psychiatry & Neurology, Neurology with Special Qualifications in Child Neurology· Philadelphia, PA

Psychiatry & Neurology, Neurology with Special Qualifications in Child Neurology (MD) in Philadelphia, Pennsylvania, licensed in PA, with an NPI issued in June 2006. Acadia Pharmaceuticals Inc reported $96.26 in payments in 2025, mostly food and beverage.

Overview

NPI1568409340
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 1, 2006
Last updated in NPPESJul 25, 2016

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$96.26 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Acadia Pharmaceuticals Inc$96.261

What the 2025 payments were for

  • Food and Beverage$96.26 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Psychiatry & Neurology, Neurology with Special Qualifications in Child Neurology providers in Philadelphia

All Psychiatry & Neurology, Neurology with Special Qualifications in Child Neurology providers in Pennsylvania →